Unknown

Dataset Information

0

Glypican-1-targeted antibody–drug conjugate inhibits the growth of glypican-1-positive glioblastoma

ABSTRACT:

SUBMITTER: Uchida S 

PROVIDER: S-EPMC10915784 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown A glypican-1-targeted antibody-drug conjugate exhibits potent tumor growth inhibition in glypican-1-positive pancreatic cancer and esophageal squamous cell carcinoma.
| S-EPMC8340053 | biostudies-literature
Unknown A CXCR4-targeted site-specific antibody-drug conjugate.
| S-EPMC4331128 | biostudies-literature
Unknown Tumor stroma-targeted antibody-drug conjugate triggers localized anticancer drug release.
| S-EPMC6025988 | biostudies-literature
Unknown HER2-Targeted Antibody-Drug Conjugate Toxicities in Breast Cancer.
| S-EPMC12685761 | biostudies-literature
Unknown Generation and Characterization of SORT1-Targeted Antibody-Drug Conjugate for the Treatment of SORT1-Positive Breast Tumor.
| S-EPMC10743877 | biostudies-literature
Unknown Antibody drug conjugate: the "biological missile" for targeted cancer therapy.
| S-EPMC8941077 | biostudies-literature
Unknown First-in-human study of DP303c, a HER2-targeted antibody-drug conjugate in patients with HER2 positive solid tumors.
| S-EPMC11393109 | biostudies-literature
Unknown Targeted Drug Delivery Using a Plug-to-Direct Antibody-Nanogel Conjugate.
| S-EPMC9928872 | biostudies-literature
Unknown Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer.
| S-EPMC5955426 | biostudies-literature
Unknown Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted Cancer Therapeutics.
| S-EPMC4624065 | biostudies-literature